Immupharma (IMM) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
WorldQuant LLC 0.47% 12-Mar-2018 View History
WorldQuant LLC 0.5% 05-Mar-2018 View History
WorldQuant LLC 0.49% 22-Feb-2018 View History
WorldQuant LLC 0.5% 21-Feb-2018 View History
WorldQuant LLC 0.49% 19-Feb-2018 View History
WorldQuant LLC 0.51% 14-Feb-2018 View History
Darwin Strategic Limited 0% 14-Oct-2013 View History
Darwin Strategic Limited 0.91% 08-Oct-2013 View History
Darwin Strategic Limited 0.87% 03-Oct-2013 View History
Darwin Strategic Limited 0.94% 01-Oct-2013 View History
Darwin Strategic Limited 1.04% 27-Sep-2013 View History
Darwin Strategic Limited 0.76% 25-Sep-2013 View History
Darwin Strategic Limited 0.6% 24-Sep-2013 View History
Darwin Strategic Limited 0.54% 23-Sep-2013 View History

mmuPharma PLC is an AIM listed (LSE:IMM) evolving speciality pharma company headquartered in London with its research R&D team, ImmuPharma Biotech, based in France

IMM research strategy is based on two strategic axes: research based on external collaboration aimed at discovering new active ingredients, which has led to the development of our most advanced project in terms of clinical development: P140 an active peptide against the auto-immune disease, Lupus SLE and internal research based on the use of molecular programming technologies, which has notably led to the development of the BioAMB and BioCIN projects.

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings